Truist Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $51.1M | Sell |
114,449
-11,744
| -9% | -$5.48M | 0.07% | 240 |
|
|
2025
Q4 | $57.2M | Sell |
126,193
-17,671
| -12% | -$7.62M | 0.08% | 223 |
|
|
2025
Q3 | $56.3M | Sell |
143,864
-66,225
| -32% | -$27.7M | 0.08% | 222 |
|
|
2025
Q2 | $93.5M | Sell |
210,089
-13,881
| -6% | -$6.4M | 0.14% | 148 |
|
|
2025
Q1 | $109M | Buy |
223,970
+12,166
| +6% | +$5.67M | 0.17% | 130 |
|
|
2024
Q4 | $85.3M | Buy |
211,804
+1,885
| +0.9% | +$874K | 0.13% | 145 |
|
|
2024
Q3 | $97.6M | Sell |
209,919
-8,722
| -4% | -$4.19M | 0.15% | 130 |
|
|
2024
Q2 | $102M | Sell |
218,641
-4,470
| -2% | -$1.94M | 0.16% | 136 |
|
|
2024
Q1 | $93.3M | Sell |
223,111
-2,245
| -1% | -$949K | 0.14% | 146 |
|
|
2023
Q4 | $91.7M | Sell |
225,356
-1,707
| -0.8% | -$631K | 0.15% | 139 |
|
|
2023
Q3 | $79M | Buy |
227,063
+58,219
| +34% | +$20.4M | 0.13% | 157 |
|
|
2023
Q2 | $59.4M | Buy |
168,844
+8,141
| +5% | +$2.74M | 0.1% | 194 |
|
|
2023
Q1 | $50.6M | Sell |
160,703
-10,741
| -6% | -$3.22M | 0.09% | 217 |
|
|
2022
Q4 | $49.5M | Buy |
171,444
+62,866
| +58% | +$19.2M | 0.09% | 212 |
|
|
2022
Q3 | $31.4M | Buy |
108,578
+1,741
| +2% | +$501K | 0.06% | 280 |
|
|
2022
Q2 | $30.1M | Sell |
106,837
-4,137
| -4% | -$1.11M | 0.06% | 305 |
|
|
2022
Q1 | $29M | Buy |
110,974
+26,836
| +32% | +$6.37M | 0.05% | 332 |
|
|
2021
Q4 | $18.5M | Buy |
84,138
+2,887
| +4% | +$561K | 0.03% | 453 |
|
|
2021
Q3 | $14.7M | Buy |
81,251
+43,511
| +115% | +$8.5M | 0.02% | 502 |
|
|
2021
Q2 | $7.61M | Buy |
37,740
+85
| +0.2% | +$17.8K | 0.01% | 730 |
|
|
2021
Q1 | $8.09M | Sell |
37,655
-1,866
| -5% | -$410K | 0.01% | 673 |
|
|
2020
Q4 | $9.34M | Sell |
39,521
-2,794
| -7% | -$641K | 0.02% | 619 |
|
|
2020
Q3 | $11.5M | Buy |
42,315
+2,825
| +7% | +$779K | 0.03% | 516 |
|
|
2020
Q2 | $11.5M | Buy |
39,490
+4,584
| +13% | +$1.24M | 0.03% | 500 |
|
|
2020
Q1 | $8.31M | Sell |
34,906
-265
| -0.8% | -$60.8K | 0.02% | 550 |
|
|
2019
Q4 | $7.7M | Buy |
35,171
+25,577
| +267% | +$5.18M | 0.02% | 638 |
|
|
2019
Q3 | $1.63M | Buy |
9,594
+83
| +0.9% | +$14.7K | 0.03% | 386 |
|
|
2019
Q2 | $1.75M | Sell |
9,511
-172
| -2% | -$30.1K | 0.03% | 373 |
|
|
2019
Q1 | $1.78M | Sell |
9,683
-94
| -1% | -$17.4K | 0.03% | 367 |
|
|
2018
Q4 | $1.62M | Sell |
9,777
-685
| -7% | -$119K | 0.03% | 369 |
|
|
2018
Q3 | $2.02M | Buy |
10,462
+104
| +1% | +$18.5K | 0.04% | 364 |
|
|
2018
Q2 | $1.76M | Sell |
10,358
-1,067
| -9% | -$165K | 0.03% | 378 |
|
|
2018
Q1 | $1.86M | Buy |
11,425
+227
| +2% | +$37.1K | 0.04% | 374 |
|
|
2017
Q4 | $1.68M | Buy |
11,198
+92
| +0.8% | +$13.6K | 0.03% | 398 |
|
|
2017
Q3 | $1.69M | Sell |
11,106
-203
| -2% | -$30.6K | 0.03% | 381 |
|
|
2017
Q2 | $1.46M | Sell |
11,309
-2,020
| -15% | -$243K | 0.03% | 403 |
|
|
2017
Q1 | $1.46M | Buy |
13,329
+5,223
| +64% | +$460K | 0.03% | 413 |
|
|
2016
Q4 | $597K | Buy |
8,106
+45
| +0.6% | +$3.66K | 0.01% | 558 |
|
|
2016
Q3 | $703K | Sell |
8,061
-340
| -4% | -$32.1K | 0.01% | 530 |
|
|
2016
Q2 | $723K | Buy |
8,401
+308
| +4% | +$26.6K | 0.02% | 530 |
|
|
2016
Q1 | $644K | Buy |
8,093
+67
| +0.8% | +$6.06K | 0.02% | 503 |
|
|
2015
Q4 | $1.01M | Buy |
8,026
+4,566
| +132% | +$551K | 0.03% | 413 |
|
|
2015
Q3 | $360K | Buy |
3,460
+1,164
| +51% | +$150K | 0.01% | 624 |
|
|
2015
Q2 | $284K | Sell |
2,296
-45
| -2% | -$5.67K | 0.01% | 669 |
|
|
2015
Q1 | $276K | Sell |
2,341
-1,725
| -42% | -$207K | 0.01% | 684 |
|
|
2014
Q4 | $483K | Sell |
4,066
-272
| -6% | -$30.6K | 0.01% | 519 |
|
|
2014
Q3 | $487K | Sell |
4,338
-214
| -5% | -$20.4K | 0.01% | 501 |
|
|
2014
Q2 | $431K | Sell |
4,552
-515
| -10% | -$36.1K | 0.01% | 543 |
|
|
2014
Q1 | $358K | Buy |
5,067
+290
| +6% | +$23K | 0.01% | 583 |
|
|
2013
Q4 | $355K | Sell |
4,777
-713
| -13% | -$49.7K | 0.01% | 584 |
|
|
2013
Q3 | $416K | Buy |
5,490
+181
| +3% | +$14.4K | 0.01% | 526 |
|
|
2013
Q2 | $425K | Buy |
+5,309
| New | +$391K | 0.02% | 513 |
|
Other funds holding VRTX
VCM
VPM
Truist Financial's VRTX Position: Q1 2026 in Review
Truist Financial reduced its Vertex Pharmaceuticals (VRTX) stake by 9.3% in Q1 2026, selling an estimated $5.48M and leaving 114,449 shares worth $51.1M. The position accounts for 0.07% of the portfolio, ranked #240.
Truist Financial first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $109M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Truist Financial held 114,449 shares of Vertex Pharmaceuticals worth $51.1M as of Q1 2026.
- Truist Financial sold 11,744 Vertex Pharmaceuticals shares in Q1 2026, an estimated $5.48M.
- Vertex Pharmaceuticals made up 0.07% of Truist Financial's portfolio in Q1 2026, its #240 holding.
- Truist Financial first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Truist Financial's Vertex Pharmaceuticals position peaked at $109M in Q1 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.